Related references
Note: Only part of the references are listed.The role of caveolin-1 in human breast cancer
Neill Patani et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Caveolin-1 in tumor progression: the good, the bad and the ugly
Jacky G. Goetz et al.
CANCER AND METASTASIS REVIEWS (2008)
Caveats of caveolin-1 in cancer progression
Elke Burgermeister et al.
CANCER LETTERS (2008)
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
Ozgur Kutuk et al.
CANCER RESEARCH (2008)
Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein
Denis Selimovic et al.
CELLULAR SIGNALLING (2008)
Taxol and 10-deacetylbaccatinIII induce distinct changes in the dynamics of caveolae
Neesar Ahmed et al.
FEBS LETTERS (2008)
Caveolin-1: an ambiguous partner in cell signalling and cancer
Andrew F. G. Quest et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis
Maria Sverdlov et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity
Ayesha N. Shajahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis
Kay Savage et al.
CLINICAL CANCER RESEARCH (2007)
Caveolin-1α and -1β perform nonredundant roles in early vertebrate development
Ping-Ke Fang et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Posttranslational modifications of Bcl2 family members - a potential therapeutic target for human malignancy
A Basu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28
EP Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (Faslodex, Fulvestrant)
KB Bouker et al.
CANCER RESEARCH (2004)
XBP-1 increases ERα transcriptional activity through regulation of large-scale chromatin unfolding
Y Fang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells
AN Shajahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Synthesis and evaluation of 17α-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17β-diols as probes for the estrogen receptor α hormone binding domain
RN Hanson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance
C Ferlini et al.
MOLECULAR PHARMACOLOGY (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis
A Basu et al.
FEBS LETTERS (2003)
The role of MAPK pathways in the action of chemotherapeutic drugs
S Boldt et al.
CARCINOGENESIS (2002)
Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?
MV Blagosklonny
BIOESSAYS (2001)
The role of ERK 1/2 and p38 MAP-kinase pathways in Taxol-induced apoptosis in human ovarian carcinoma cells
R Seidman et al.
EXPERIMENTAL CELL RESEARCH (2001)
MEK inhibition enhances paclitaxel-induced tumor apoptosis
JP MacKeigan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European organization for research and treatment of cancer randomized study with cross-over
R Paridaens et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Multiple domains in caveolin-1 control its intracellular traffic
T Machleidt et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
